{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T07:09:16Z","timestamp":1773644956969,"version":"3.50.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Concussion triggers rapid and transient surges in extracellular amino acids, largely driven by pathological activation of N-methyl-D-aspartate (NMDA) receptors. Targeting this ultra-acute excitotoxic window remains challenging, in part because many NMDA receptor antagonists exhibit slow delivery kinetics or limited brain penetrance when administered systemically. Intranasal drug delivery may help overcome these limitations by enabling faster central nervous system access. Here, we compared the capacity of intranasally administered MK-801, a high-affinity non-competitive NMDA receptor antagonist, and intranasal ketamine, a clinically used antagonist with distinct pharmacokinetic and receptor-binding properties, to modulate early neurochemical responses following experimental concussion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Adult rats underwent a validated weight-drop concussion model followed by continuous hippocampal microdialysis. Extracellular glutamate, taurine, glycine, gamma-aminobutyric acid, glutamine, and serine were quantified every 10\u00a0min for 60\u00a0min before and after injury using high-performance liquid chromatography. Animals received intranasal MK-801 (10\u00a0mg\/kg), ketamine (10\u00a0mg\/kg), or vehicle immediately after concussion or sham procedures. Righting time was recorded as an early post-treatment behavioral outcome. MK-801 concentrations in plasma and brain were quantified by liquid chromatography-tandem mass spectrometry to assess central exposure. A composite excitotoxic index was calculated to summarize excitatory-inhibitory neurochemical imbalance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Vehicle-treated concussed animals exhibited marked elevations in glutamate, taurine, and glycine within the first 10\u00a0min post-injury, accompanied by prolonged righting times. Intranasal MK-801 attenuated these ultra-acute neurochemical surges, reduced the composite excitotoxic index, and was associated with shorter righting times comparable to those observed in sham animals. In contrast, intranasal ketamine did not significantly alter amino acid dynamics or righting time under the conditions tested. MK-801 achieved measurable brain exposure following intranasal administration, with comparable brain-to-plasma ratios in sham and concussed animals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Intranasal delivery of MK-801 modulates ultra-acute excitotoxic neurochemical disturbances following concussion in a rodent model. The lack of comparable effects with ketamine under the tested conditions highlights the importance of pharmacokinetic properties and receptor-binding kinetics when targeting the brief post-injury excitotoxic window. These findings provide proof-of-concept evidence supporting further investigation of rapid intranasal NMDA receptor antagonism as a strategy to influence early glutamatergic dysregulation after concussion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1764201","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T06:36:34Z","timestamp":1773642994000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intranasal delivery of the NMDA receptor antagonist MK-801 attenuates ultra-acute excitotoxic neurochemical responses after concussion in rats: comparative pharmacological evaluation against ketamine"],"prefix":"10.3389","volume":"17","author":[{"given":"Ian","family":"Masse","sequence":"first","affiliation":[{"name":"Research Center, H\u00f4pital du Sacr\u00e9-C\u0153ur de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Moquin","sequence":"additional","affiliation":[{"name":"Research Center, Douglas Institute","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Bouchard","sequence":"additional","affiliation":[{"name":"Research Center, H\u00f4pital du Sacr\u00e9-C\u0153ur de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurianne","family":"Legroux","sequence":"additional","affiliation":[{"name":"Research Center, H\u00f4pital du Sacr\u00e9-C\u0153ur de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Gratton","sequence":"additional","affiliation":[{"name":"Research Center, Douglas Institute","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"De Beaumont","sequence":"additional","affiliation":[{"name":"Research Center, H\u00f4pital du Sacr\u00e9-C\u0153ur de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/biomedicines9121834","article-title":"Drug delivery challenges in brain disorders across the blood-brain barrier: novel methods and future considerations for improved therapy","volume":"9","author":"Achar","year":"2021","journal-title":"Biomedicines"},{"key":"B2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini","year":"2001","journal-title":"Behav. Brain Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","article-title":"Intranasal treatment of central nervous system dysfunction in humans","volume":"30","author":"Chapman","year":"2013","journal-title":"Pharm. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1523\/JNEUROSCI.3481-08.2009","article-title":"HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine","volume":"29","author":"Chen","year":"2009","journal-title":"J. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/pharmaceutics14030629","article-title":"Evaluation of recent intranasal drug delivery systems to the central nervous system","volume":"14","author":"Crowe","year":"2022","journal-title":"Pharmaceutics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"B7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4155\/tde.14.41","article-title":"The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview","volume":"5","author":"Djupesland","year":"2014","journal-title":"Ther. Deliv."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1227\/NEU.0000000000000505","article-title":"The new neurometabolic cascade of concussion","volume":"75","author":"Giza","year":"2014","journal-title":"Neurosurgery"},{"key":"B10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0304-3940(91)90889-2","article-title":"Excitotoxic index--a biochemical marker of selective vulnerability","volume":"127","author":"Globus","year":"1991","journal-title":"Neurosci. Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"114786","DOI":"10.1016\/j.bcp.2021.114786","article-title":"Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: opportunities for novel therapeutics development","volume":"193","author":"Green","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6104","DOI":"10.1038\/s41380-021-01167-1","article-title":"Unraveling the opioid actions of S-ketamine and R-ketamine: comment on Bonaventura et al","volume":"26","author":"Heifets","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1073\/pnas.85.4.1307","article-title":"Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels","volume":"85","author":"Huettner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s1474-4422(02)00164-3","article-title":"Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?","volume":"1","author":"Ikonomidou","year":"2002","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/s0168-3659(02)00363-2","article-title":"Nasal drug delivery--possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control Release"},{"key":"B17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/325529a0","article-title":"Glycine potentiates the NMDA response in cultured mouse brain neurons","volume":"325","author":"Johnson","year":"1987","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1203\/00006450-200106000-00003","article-title":"Neurobiology of hypoxic-ischemic injury in the developing brain","volume":"49","author":"Johnston","year":"2001","journal-title":"Pediatr. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/s0028-3908(01)00041-7","article-title":"The in vivo relevance of the varied channel-blocking properties of uncompetitive NMDA antagonists: tests on spinal neurones","volume":"41","author":"Jones","year":"2001","journal-title":"Neuropharmacology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3171\/jns.1990.73.6.0889","article-title":"Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury","volume":"73","author":"Katayama","year":"1990","journal-title":"J. Neurosurg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s43440-021-00232-4","article-title":"Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms","volume":"73","author":"Kohtala","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.pneurobio.2013.11.006","article-title":"Excitotoxicity and stroke: identifying novel targets for neuroprotection","volume":"115","author":"Lai","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00001199-200609000-00001","article-title":"The epidemiology and impact of traumatic brain injury: a brief overview","volume":"21","author":"Langlois","year":"2006","journal-title":"J. Head. Trauma Rehabil."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2202-11-5","article-title":"The problem of pseudoreplication in neuroscientific studies: is it affecting your analysis?","volume":"11","author":"Lazic","year":"2010","journal-title":"BMC Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1602\/neurorx.1.1.101","article-title":"Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults","volume":"1","author":"Lipton","year":"2004","journal-title":"NeuroRx"},{"key":"B26","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.1523\/JNEUROSCI.1187-10.2010","article-title":"Interhemispheric regulation of the medial prefrontal cortical glutamate stress response in rats","volume":"30","author":"Lupinsky","year":"2010","journal-title":"J. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","article-title":"Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research","volume":"16","author":"Maas","year":"2017","journal-title":"Lancet Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1152\/jn.90880.2008","article-title":"Presynaptic and postsynaptic NMDA receptors mediate distinct effects of brain-derived neurotrophic factor on synaptic transmission","volume":"100","author":"Madara","year":"2008","journal-title":"J. Neurophysiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e59585","DOI":"10.3791\/59585","article-title":"A novel and translational rat model of concussion combining force and rotation with in vivo cerebral microdialysis","author":"Masse","year":"2019","journal-title":"J. Vis. Exp"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3171\/2021.3.JNS204163","article-title":"Efficacy of prophylactic versus therapeutic administration of the NMDA receptor antagonist MK-801 on the acute neurochemical response to a concussion in a rat model combining force and rotation","volume":"136","author":"Masse","year":"2021","journal-title":"J. Neurosurg."},{"key":"B31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The spectrum of disease in chronic traumatic encephalopathy","volume":"136","author":"Mckee","year":"2013","journal-title":"Brain"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1080\/13854046.2018.1508616","article-title":"A systematic review of sex differences in concussion outcome: what do we know?","volume":"33","author":"Merritt","year":"2019","journal-title":"Clin. Neuropsychol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"678971","DOI":"10.3389\/fneur.2021.678971","article-title":"Systematic review of sex and gender effects in traumatic brain injury: equity in clinical and functional outcomes","volume":"12","author":"Mollayeva","year":"2021","journal-title":"Front. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jpsychires.2019.02.003","article-title":"Brain penetration of ketamine: intranasal delivery VS parenteral routes of administraion","volume":"112","author":"Naidoo","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/jcbfm.1990.115","article-title":"Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats","volume":"10","author":"Nilsson","year":"1990","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1089\/neu.1997.14.677","article-title":"Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury?","volume":"14","author":"Obrenovitch","year":"1997","journal-title":"J. Neurotrauma"},{"key":"B37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0304-3940(92)90040-e","article-title":"Pretreatment with NMDA antagonists limits release of excitatory amino acids following traumatic brain injury","volume":"136","author":"Panter","year":"1992","journal-title":"Neurosci. Lett."},{"key":"B38","volume-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1998"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e70213","DOI":"10.1002\/mco2.70213","article-title":"The nasal-brain drug delivery route: mechanisms and applications to central nervous system diseases","volume":"6","author":"Qiu","year":"2025","journal-title":"MedComm"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/nu14061292","article-title":"Taurine supplementation as a neuroprotective strategy upon brain dysfunction in metabolic syndrome and diabetes","volume":"14","author":"Rafiee","year":"2022","journal-title":"Nutrients"},{"key":"B41","doi-asserted-by":"publisher","first-page":"937789","DOI":"10.3389\/fnmol.2022.937789","article-title":"Taurine and astrocytes: a homeostatic and neuroprotective relationship","volume":"15","author":"Ramirez-Guerrero","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/sj.npp.1300642","article-title":"Selective cognitive impairments associated with NMDA receptor blockade in humans","volume":"30","author":"Rowland","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"974666","DOI":"10.3389\/fphar.2022.974666","article-title":"Intranasal delivery: an attractive route for the administration of nucleic acid based therapeutics for CNS disorders","volume":"13","author":"Shah","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/jnc.13741","article-title":"Glycine release from astrocytes via functional reversal of GlyT1","volume":"140","author":"Shibasaki","year":"2017","journal-title":"J. Neurochem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/neu.2000.17.1179","article-title":"Isoflurane improves long-term neurologic outcome versus fentanyl after traumatic brain injury in rats","volume":"17","author":"Statler","year":"2000","journal-title":"J. Neurotrauma"},{"key":"B46","doi-asserted-by":"publisher","first-page":"120152","DOI":"10.1016\/j.jns.2022.120152","article-title":"Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence","volume":"434","author":"Subramanian","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"869269","DOI":"10.1155\/2014\/869269","article-title":"Drug delivery systems, CNS protection, and the blood brain barrier","volume":"2014","author":"Upadhyay","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B48","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1073\/pnas.83.18.7104","article-title":"The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist","volume":"83","author":"Wong","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B49","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/pharmaceutics16060774","article-title":"Intranasal delivery of cell-penetrating therapeutic peptide enhances brain delivery, reduces inflammation, and improves neurologic function in moderate traumatic brain injury","volume":"16","author":"Yanamadala","year":"2024","journal-title":"Pharmaceutics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"116945","DOI":"10.1016\/j.jpba.2025.116945","article-title":"Pharmacokinetics and brain distribution of ketamine after nasal administration","volume":"264","author":"Yang","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B51","doi-asserted-by":"publisher","first-page":"20417314251372373","DOI":"10.1177\/20417314251372373","article-title":"Intranasal delivery systems for traumatic brain injury: advancements and perspectives","volume":"16","author":"Yoo","year":"2025","journal-title":"J. Tissue Eng."},{"key":"B52","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/jcbfm.2013.113","article-title":"Regenerative glutamate release by presynaptic NMDA receptors contributes to spreading depression","volume":"33","author":"Zhou","year":"2013","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B54","doi-asserted-by":"publisher","first-page":"11158","DOI":"10.1523\/JNEUROSCI.1547-16.2016","article-title":"Ketamine: NMDA receptors and beyond","volume":"36","author":"Zorumski","year":"2016","journal-title":"J. Neurosci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1764201\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T06:36:37Z","timestamp":1773642997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1764201\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":54,"alternative-id":["10.3389\/fphar.2026.1764201"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1764201","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"article-number":"1764201"}}